391 related articles for article (PubMed ID: 15088499)
1. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome.
Engel WK
Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499
[TBL] [Abstract][Full Text] [Related]
2. Bilateral phrenic neuropathies in a diabetic patient responsive to intravenous immunoglobulin: a case report.
Rison RA; Beydoun SR
Clin Neurol Neurosurg; 2011 Nov; 113(9):788-91. PubMed ID: 21906870
[TBL] [Abstract][Full Text] [Related]
3. Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropathy types of painful diabetic neuropathy.
Kawagashira Y; Watanabe H; Morozumi S; Iijima I; Koike H; Hattori N; Sobue G
J Clin Neurosci; 2010 Aug; 17(8):1003-8. PubMed ID: 20627580
[TBL] [Abstract][Full Text] [Related]
4. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
5. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
6. An unusual neuropathy in a diabetic patient: evidence for intravenous immunoglobin-induced effective therapy.
Romedenne P; Mukendi R; Stasse P; Indekeu P; Buysschaert M; Colin IM
Diabetes Metab; 2001 Apr; 27(2 Pt 1):155-8. PubMed ID: 11353882
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
8. Long-term response of neuropathic pain to intravenous immunoglobulin in relapsing diabetic lumbosacral radiculoplexus neuropathy. A case report.
Tamburin S; Magrinelli F; Favaro F; Briani C; Zanette G
Pain Pract; 2014 Feb; 14(2):E85-90. PubMed ID: 24152254
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin therapy in the inflammatory neuropathies.
Churchyard A; Day T; Grainger K; Mastaglia FL
Clin Exp Neurol; 1991; 28():168-79. PubMed ID: 1821824
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol: a pilot study on safety and clinical efficacy in neuropathies of diabetes mellitus type 2 (ASCEND).
Rosales RL; Santos MM; Mercado-Asis LB
Angiology; 2011 Nov; 62(8):625-35. PubMed ID: 21733952
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
12. How We Treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin Therapy.
Schofield JR; Chemali KR
Eur Neurol; 2018; 80(5-6):304-310. PubMed ID: 30889595
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
Apfel SC; Schwartz S; Adornato BT; Freeman R; Biton V; Rendell M; Vinik A; Giuliani M; Stevens JC; Barbano R; Dyck PJ
JAMA; 2000 Nov; 284(17):2215-21. PubMed ID: 11056593
[TBL] [Abstract][Full Text] [Related]
14. An idiopathic thrombocytopenic purpura with polyneuropathy.
Katchan V; David P; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):193-196. PubMed ID: 27427299
[TBL] [Abstract][Full Text] [Related]
15. Acute motor neuropathy with pure distal involvement--a case report of multifocal motor neuropathy.
Ramdas S; Prasad M; Spillane K; Kirkpatrick M
Eur J Paediatr Neurol; 2013 Jul; 17(4):415-8. PubMed ID: 23416060
[TBL] [Abstract][Full Text] [Related]
16. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of neuropathies in patients with diabetes mellitus.
Krendel DA; Costigan DA; Hopkins LC
Arch Neurol; 1995 Nov; 52(11):1053-61. PubMed ID: 7487556
[TBL] [Abstract][Full Text] [Related]
18. [Long-term follow-up of multifocal motor neuropathy with conduction block under intravenous immunoglobulin].
Delmont E; Azulay JP; Uzenot D; Attarian S; Verschueren A; Pouget J
Rev Neurol (Paris); 2007 Jan; 163(1):82-8. PubMed ID: 17304176
[TBL] [Abstract][Full Text] [Related]
19. Cross sectional study to evaluate the effect of duration of type 2 diabetes mellitus on the nerve conduction velocity in diabetic peripheral neuropathy.
Hussain G; Rizvi SA; Singhal S; Zubair M; Ahmad J
Diabetes Metab Syndr; 2014; 8(1):48-52. PubMed ID: 24661759
[TBL] [Abstract][Full Text] [Related]
20. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment.
Dalakas MC; Engel WK
Ann Neurol; 1981; 9 Suppl():134-45. PubMed ID: 7224612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
